| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ellis Andrea is a Director at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 17,167 | $49.00 | $841,183.00 | -48.0% | +26.0% | - | |
| Apr 14, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 10,000 | $35.00 | $350,000.00 | -45.5% | +36.8% | +114.0% | |
| Apr 1, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 30,000 | $34.05 | $1,021,500.00 | -71.4% | +30.8% | +125.5% | |
| Mar 15, 2022 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 12,000 | $8.39 | $100,680.00 | New | -30.1% | +67.5% |